Article

Pharmaceutical Technology's In the Lab eNewsletter

In the Lab eNewsletter

Pharmaceutical Technology\'s In the Lab eNewsletter-12-04-2019
Volume14
Issue 12

Definer DF2000 Knife Mill from Franklin Miller Offers Ease of Use

The device focuses on ease of maintenance and reliability while cutting materials to desired output size without overgrinding or excessive heat build-up.

The Definer DF2000 knife mill from Franklin Miller focuses on ease of maintenance and reliability while cutting materials to desired output size without overgrinding or excessive heat build-up. The company introduced the product on Nov. 14, 2019.

The device’s rotor design comes equipped with replaceable rotary knife elements and several cutter elements and screen sizes that allow for the customization of the condition, mill, and deagglomerate of the device. The stainless-steel hopper and protective flaps help to keep work environments clean, while the rotational speed, particle size, and throughput are maintained with the knife mill’s variable speed controller. Additional add-ons are also available and include casters with lockable wheels and a pneumatic discharge system.

Source: Franklin Miller

 

 

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More